| 000 | 01872 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250516192235.0 | ||
| 264 | 0 | _c20160106 | |
| 008 | 201601s 0 0 eng d | ||
| 022 | _a1520-6777 | ||
| 024 | 7 |
_a10.1002/nau.22560 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHumblet, Martien | |
| 245 | 0 | 0 |
_aLong-term outcome of intravesical oxybutynin in children with detrusor-sphincter dyssynergia: with special reference to age-dependent parameters. _h[electronic resource] |
| 260 |
_bNeurourology and urodynamics _cApr 2015 |
||
| 300 |
_a336-42 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Intravesical |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDiagnostic Techniques, Urological |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMandelic Acids _xadministration & dosage |
| 650 | 0 | 4 |
_aMuscarinic Antagonists _xadministration & dosage |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aUrethra _xdrug effects |
| 650 | 0 | 4 |
_aUrinary Bladder _xdrug effects |
| 650 | 0 | 4 |
_aUrinary Bladder, Neurogenic _xdiagnosis |
| 650 | 0 | 4 |
_aUrinary Bladder, Overactive _xdiagnosis |
| 650 | 0 | 4 |
_aUrodynamics _xdrug effects |
| 650 | 0 | 4 |
_aUrological Agents _xadministration & dosage |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aVerpoorten, Carla | |
| 700 | 1 | _aChristiaens, Maria-Helena | |
| 700 | 1 | _aHirche, Herbert | |
| 700 | 1 | _aJansen, Katrien | |
| 700 | 1 | _aBuyse, Gunnar | |
| 700 | 1 | _avan Gool, Jan D | |
| 773 | 0 |
_tNeurourology and urodynamics _gvol. 34 _gno. 4 _gp. 336-42 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/nau.22560 _zAvailable from publisher's website |
| 999 |
_c23459889 _d23459889 |
||